Study title:
Yaniv-I, Saab-A, Cohen-I-J, Goshen-Y, Loven-D, Stark-B, Tamary-H, Zaizov-R. Department of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology, {J-Pediatr- Hematol-Oncol}, Feb 1996, vol. 18, no. 1, p. 76-80, ISSN: 1077-4114.Yaniv-I, Saab-A, Cohen-I-J, Goshen-Y, Loven-D, Stark-B, Tamary-H, Zaizov-R. Department of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease.
Journal of pediatric hem...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|